ipamorelin side effects clinical studies In Women ipamorelin clinical trials side effects

But deliberately driving IGF-1 signaling high and keeping it there is a different thing, and it's the reason a careful personal and family history is non-negotiable before anyone considers this compound

doi:10.1210/jc.2006-1702 (source) Van Hout MC, Hearne E

[7] Modified GRF 1-29 & Ipamorelin peptide combination may have a high growth hormone-receptor sensitivity and act via mechanisms including increased Insulin-Like Growth Factor 1 (IGF-1) levels, leading to muscle cell proliferation

It has also shown some muscle building potential

The peptide has a relatively short half-life of approximately 20 minutes, meaning it clears the body quickly while stimulating growth hormone release that lasts much longer